As seen on the NueroDiversity Weblog, intensive documentation regarding the problemativ promotion of a treament for autism that might not be as effective or as safe as desired.
Preliminary Articles
Autism & Lupron: Playing With Fire (February 19, 2006)
About the role played by journalists in the dissemination of scientific
misinformation about autism, and the early development of Mark and David Geier’s “Lupron protocol.”
Patent Medicine (April 5, 2006)
About Mark and David Geier’s applications to patent the “Lupron protocol.”
Significant Misrepresentations:
Mark Geier, David Geier & the Evolution of the Lupron Protocol
Significant Misrepresentations, Part One
An Inaccurate Byline (June 9, 2006)
About the appearance of a misleading statement of affiliation in the
byline of an article by Mark Geier and David Geier, published in the
journal Hormone Research.
Significant Misrepresentations, Part Two
An Elusive Institute (June 20, 2006)
About the “Institute for Chronic Illnesses” and its Institutional
Review Board, established by Mark Geier to supervise his and his son’s
own research, with members drawn from the ranks of patients’ parents,
business associates and political allies.
Significant Misrepresentations, Part Three
A Dubious Diagnosis (June 26, 2006)
About the increase in numbers of autistic children diagnosed with central precocious puberty and administered Lupron, and the criteria according to which those
diagnoses are being proferred.
Significant Misrepresentations, Part Four
On Questionable Terms (June 29, 2006)
About the shifting terminology used by Mark and David Geier to refer to
the condition supposedly experienced by autistic children being treated
with Lupron, raising questions about the means by which insurance
companies are being persuaded to reimburse the costs of the treatment.
Significant Misrepresentations, Part Five
Testimony of the Faithful (July 12, 2006)
About the promotional assistance provided to Mark and David Geier by the parents of research subjects and political allies.
Significant Misrepresentations, Update
A Republished Article (July 13, 2006)
About the amendment and republication of Mark and David Geier’s article
by Hormone Research, in spite of documented irregularities with their
Institutional Review Board.
Significant Misrepresentations, Part Six
“Desperation Time” (July 20, 2006)
A partial transcript of an interview with Mark Geier on the conspiracy talk show, Radio Liberty.
Significant Misrepresentations, Part Seven
The Citations Are Not What They Seem (July 24, 2006)
About the manner in which Mark and David Geier cite the work of other
researchers to substantiate their claims about the “Lupron protocol.”
Significant Misrepresentations, Part Eight
Bibliographic Mergers & Acquisitions (August 10, 2006)
About the striking similarities between two articles written by Mark
and David Geier, and a June 2000 draft of a study by researchers at the
Centers for Disease Control.
Significant Misrepresentations, Part Nine
Blood & Data (August 25, 2006)
About the extensive phlebotomy and laboratory testing performed on
children being evaluated for participation in the Geiers’ study and
possible treatment with Lupron.
Significant Misrepresentations, Part Ten
TAP’s Connection (August 29, 2006)
About the application to patent the “Lupron Protocol” submitted by Mark and David Geier and TAP Pharmaceuticals.
Related Articles
Foreordained Conclusions (March 8, 2006)
Commentary on the article, Early Downward Trends in Neurodevelopmental Disorders Following Removal of Thimerosal-Containing Vaccines.
Strange Bedfellows (March 12, 2006)
About the philosophical, political and antivaccinationist agenda of the Association of American Physicians and Surgeons.
Strategic Disregard (March 24, 2006)
About Mark and David Geier’s IRB approval to conduct a study of the Vaccine Safety Datalink.
Plaintiffs’ Gambit Failed (July 11, 2006)
The full text of Judge James A. Beaty’s opinion in the case Doe vs.
Ortho-Clinical Diagnostics, in which Dr. Mark Geier was excluded as an
expert witness due to a lack of relevant qualifications and failure to
properly diagnose.
No comments:
Post a Comment